Trial intelligence / Profile preview

Modified Del Nido versus conventional blood crystalloid cardioplegia in adult cardiac surgery

PACTR202207730603285Phase 2Completed

Sponsor
Kasr Al Ainy Hospital
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of modified del Nido cardioplegia in None (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Rhythm after removal of aortic cross clamp. Started Nov 2020; status: completed.

02

Drugs

modified del Nido cardioplegia

Beyond the preview

Go deeper on PACTR202207730603285.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202207730603285.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call